Hydromorphon: Präferenzsubstanz in der Tumorschmerztherapie
Crossref DOI link: https://doi.org/10.1007/s42090-019-0228-1
Published Online: 2019-05-31
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Herrmann, Matthias
Text and Data Mining valid from 2019-05-31
Version of Record valid from 2019-05-31
Article History
First Online: 31 May 2019
Free to read: This content has been made available to all.